Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dihydrotanshinone I targets ESR1 to induce DNA double-strand breaks and proliferation inhibition in hepatocellular carcinoma

Phytomedicine(2024)10.1016/j.phymed.2024.155767Source: DataRank Database

Dihydrotanshinone I targets ESR1 to induce DNA double-strand breaks and proliferation inhibition in hepatocellular carcinoma is a research paper published in Phytomedicine (2024). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 10.66)OA: hybridTopics (61)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Junbin Yan ORCID,Xueru Huang,Tao Jiang ORCID,Shuo Zhang ORCID,Guangji Zhang ORCID

Live enrichment

PubMed:38833789 OpenAlex:https://openalex.org/W4398762747

Department of Education of Zhejiang Province

Grant: Y202351265

Department of Education of Zhejiang Province

Grant: 82204950

Department of Education of Zhejiang Province

Grant: 81973598

Department of Education of Zhejiang Province

Grant: 82074214

Natural Science Foundation of Zhejiang Province

Grant: LQ23H270013

National Natural Science Foundation of China

Grant: 82030119

National Institutes of Health

Grant: 2023-LW-028-01

National Institutes of Health

Grant: IACUC-20230206-03

Zhejiang Chinese Medical University

FWCI

10.66

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.phymed.2024.155767

HYBRIDhttps://doi.org/10.1016/j.phymed.2024.155767

publisherhttps://doi.org/10.1016/j.phymed.2024.155767

publisherhttps://api.elsevier.com/content/article/PII:S0944711324004264?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0944711324004264?httpAccept=text/plain

Fields of Study

Traditional Chinese Medicine AnalysisEstrogen and related hormone effectsPhytochemical Studies and BioactivitiesMedicineChemistryCarcinoma, HepatocellularEstrogen Receptor alphaLiver NeoplasmsHumansCell ProliferationPhenanthrenesAnimalsDNA Breaks, Double-StrandedCell Line, TumorMice, NudeMaleApoptosisMiceHep G2 CellsFuransQuinones

MeSH Terms

AnimalsFuransCarcinoma, HepatocellularHumansLiver NeoplasmsMaleMice, NudePhenanthrenesQuinonesApoptosisCell Line, TumorEstrogen Receptor alphaCell ProliferationMiceDNA Breaks, Double-StrandedHep G2 Cells

Keywords

Estrogen receptorEstrogenEstrogen receptor alphaCancer researchHepatocellular carcinomaTamoxifenSalvia miltiorrhizaIn vivoDownregulation and upregulationMedicineCancerChemistryBiologyInternal medicineBreast cancerGeneGeneticsBiochemistryPathologyDNA double-strand breaksestrogen replacement therapyGender DifferenceEstrogen Receptor ΑDihydrotanshinone I